ID   DGKG_HUMAN              Reviewed;         791 AA.
AC   P49619; B2RAH4; Q2M1H4; Q5FWG1;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   10-MAY-2017, entry version 169.
DE   RecName: Full=Diacylglycerol kinase gamma;
DE            Short=DAG kinase gamma;
DE            EC=2.7.1.107;
DE   AltName: Full=Diglyceride kinase gamma;
DE            Short=DGK-gamma;
GN   Name=DGKG; Synonyms=DAGK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT LYS-316.
RC   TISSUE=Liver;
RX   PubMed=8034597;
RA   Kai M., Sakane F., Imai S., Wada I., Kanoh H.;
RT   "Molecular cloning of a diacylglycerol kinase isozyme predominantly
RT   expressed in human retina with a truncated and inactive enzyme
RT   expression in most other human cells.";
RL   J. Biol. Chem. 269:18492-18498(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LYS-316.
RX   PubMed=10071200; DOI=10.1007/s004390050917;
RA   Stoehr H., Klein J., Gehrig A., Koehler M.R., Jurklies B., Kellner U.,
RA   Leo-Kottler B., Schmid M., Weber B.H.F.;
RT   "Mapping and genomic characterization of the gene encoding
RT   diacylglycerol kinase gamma (DAGK3): assessment of its role in
RT   dominant optic atrophy (OPA1).";
RL   Hum. Genet. 104:99-105(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   SER-142 AND LYS-316.
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND
RP   VARIANTS SER-142 AND LYS-316.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-706.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Reverses the normal flow of glycerolipid biosynthesis by
CC       phosphorylating diacylglycerol back to phosphatidic acid.
CC   -!- CATALYTIC ACTIVITY: ATP + 1,2-diacyl-sn-glycerol = ADP + 1,2-
CC       diacyl-sn-glycerol 3-phosphate.
CC   -!- ENZYME REGULATION: Requires phosphatidylserine for maximal
CC       activity.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Membrane. Note=Can be loosely
CC       bound to the membranes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long;
CC         IsoId=P49619-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P49619-2; Sequence=VSP_001267;
CC         Note=May be inactive.;
CC       Name=3;
CC         IsoId=P49619-3; Sequence=VSP_039922;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in retina and in a
CC       much lesser extent in the brain. Other tissues contain extremely
CC       low levels of DGK-gamma.
CC   -!- SIMILARITY: Belongs to the eukaryotic diacylglycerol kinase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D26135; BAA05132.1; -; mRNA.
DR   EMBL; AF020945; AAC04686.1; -; Genomic_DNA.
DR   EMBL; AF020922; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020923; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020924; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020925; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020926; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020927; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020928; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020929; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020930; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020931; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020932; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020933; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020934; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020935; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020936; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020937; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020938; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020939; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020940; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020941; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020942; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020943; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AF020944; AAC04686.1; JOINED; Genomic_DNA.
DR   EMBL; AK314192; BAG36871.1; -; mRNA.
DR   EMBL; AC007917; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112649; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC089411; AAH89411.1; -; mRNA.
DR   EMBL; BC112363; AAI12364.1; -; mRNA.
DR   CCDS; CCDS3274.1; -. [P49619-1]
DR   CCDS; CCDS43181.1; -. [P49619-3]
DR   CCDS; CCDS43182.1; -. [P49619-2]
DR   PIR; A53691; A53691.
DR   RefSeq; NP_001074213.1; NM_001080744.1. [P49619-2]
DR   RefSeq; NP_001074214.1; NM_001080745.1. [P49619-3]
DR   RefSeq; NP_001337.2; NM_001346.2. [P49619-1]
DR   UniGene; Hs.683449; -.
DR   ProteinModelPortal; P49619; -.
DR   SMR; P49619; -.
DR   BioGrid; 107978; 2.
DR   IntAct; P49619; 2.
DR   STRING; 9606.ENSP00000265022; -.
DR   ChEMBL; CHEMBL1075157; -.
DR   DrugBank; DB00144; Phosphatidyl serine.
DR   SwissLipids; SLP:000000923; -.
DR   SwissLipids; SLP:000000938; -. [P49619-1]
DR   iPTMnet; P49619; -.
DR   PhosphoSitePlus; P49619; -.
DR   BioMuta; DGKG; -.
DR   DMDM; 311033457; -.
DR   EPD; P49619; -.
DR   PaxDb; P49619; -.
DR   PeptideAtlas; P49619; -.
DR   PRIDE; P49619; -.
DR   DNASU; 1608; -.
DR   Ensembl; ENST00000265022; ENSP00000265022; ENSG00000058866. [P49619-1]
DR   Ensembl; ENST00000344484; ENSP00000339777; ENSG00000058866. [P49619-2]
DR   Ensembl; ENST00000382164; ENSP00000371599; ENSG00000058866. [P49619-3]
DR   GeneID; 1608; -.
DR   KEGG; hsa:1608; -.
DR   UCSC; uc003fqa.4; human. [P49619-1]
DR   CTD; 1608; -.
DR   DisGeNET; 1608; -.
DR   GeneCards; DGKG; -.
DR   HGNC; HGNC:2853; DGKG.
DR   HPA; HPA036577; -.
DR   MIM; 601854; gene.
DR   neXtProt; NX_P49619; -.
DR   OpenTargets; ENSG00000058866; -.
DR   PharmGKB; PA27314; -.
DR   eggNOG; KOG1169; Eukaryota.
DR   eggNOG; ENOG410XQVB; LUCA.
DR   GeneTree; ENSGT00760000119050; -.
DR   HOGENOM; HOG000252931; -.
DR   HOVERGEN; HBG051345; -.
DR   InParanoid; P49619; -.
DR   KO; K00901; -.
DR   OMA; CYQSVTA; -.
DR   OrthoDB; EOG091G04A5; -.
DR   PhylomeDB; P49619; -.
DR   TreeFam; TF313104; -.
DR   BRENDA; 2.7.1.107; 2681.
DR   Reactome; R-HSA-114508; Effects of PIP2 hydrolysis.
DR   SABIO-RK; P49619; -.
DR   ChiTaRS; DGKG; human.
DR   GeneWiki; DGKG; -.
DR   GenomeRNAi; 1608; -.
DR   PRO; PR:P49619; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000058866; -.
DR   CleanEx; HS_DGKG; -.
DR   ExpressionAtlas; P49619; baseline and differential.
DR   Genevisible; P49619; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004143; F:diacylglycerol kinase activity; IDA:BHF-UCL.
DR   GO; GO:0003951; F:NAD+ kinase activity; IEA:InterPro.
DR   GO; GO:0046486; P:glycerolipid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0046834; P:lipid phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 3.40.50.10330; -; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_dom_1.
DR   InterPro; IPR029477; DAG_kinase_typeI_N.
DR   InterPro; IPR000756; Diacylglycerol_kin_accessory.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF14513; DAG_kinase_N; 1.
DR   Pfam; PF00609; DAGK_acc; 1.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00045; DAGKa; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF111331; SSF111331; 1.
DR   SUPFAM; SSF47473; SSF47473; 3.
DR   PROSITE; PS50146; DAGK; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Calcium; Complete proteome;
KW   Cytoplasm; Kinase; Membrane; Metal-binding; Nucleotide-binding;
KW   Polymorphism; Reference proteome; Repeat; Transferase; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    791       Diacylglycerol kinase gamma.
FT                                /FTId=PRO_0000218459.
FT   DOMAIN      175    210       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      220    255       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      430    564       DAGKc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   CA_BIND     188    199       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     233    244       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   ZN_FING     271    321       Phorbol-ester/DAG-type 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   ZN_FING     336    385       Phorbol-ester/DAG-type 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   COMPBIAS    151    156       Poly-Ser.
FT   VAR_SEQ     334    372       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039922.
FT   VAR_SEQ     451    475       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001267.
FT   VARIANT     142    142       T -> S (in dbSNP:rs1004588).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_020259.
FT   VARIANT     316    316       R -> K (in dbSNP:rs2193587).
FT                                {ECO:0000269|PubMed:10071200,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8034597}.
FT                                /FTId=VAR_024430.
FT   VARIANT     370    370       R -> W (in dbSNP:rs3213770).
FT                                /FTId=VAR_020260.
FT   VARIANT     706    706       E -> K (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036119.
FT   CONFLICT    271    271       R -> G (in Ref. 1; BAA05132 and 2;
FT                                AAC04686). {ECO:0000305}.
SQ   SEQUENCE   791 AA;  89124 MW;  A1382CF1B2CD7362 CRC64;
     MGEERWVSLT PEEFDQLQKY SEYSSKKIKD ALTEFNEGGS LKQYDPHEPI SYDVFKLFMR
     AYLEVDLPQP LSTHLFLAFS QKPRHETSDH PTEGASNSEA NSADTNIQNA DNATKADEAC
     APDTESNMAE KQAPAEDQVA ATPLEPPVPR SSSSESPVVY LKDVVCYLSL LETGRPQDKL
     EFMFRLYDSD ENGLLDQAEM DCIVNQMLHI AQYLEWDPTE LRPILKEMLQ GMDYDRDGFV
     SLQEWVHGGM TTIPLLVLLG MDDSGSKGDG RHAWTMKHFK KPTYCNFCHI MLMGVRKQGL
     CCTYCKYTVH ERCVSRNIPG CVKTYSKAKR SGEVMQHAWV EGNSSVKCDR CHKSIKCYQS
     VTARHCVWCR MTFHRKCELS TLCDGGELRD HILLPTSICP ITRDRPGEKS DGCVSAKGEL
     VMQYKIIPTP GTHPLLVLVN PKSGGRQGER ILRKFHYLLN PKQVFNLDNG GPTPGLNFFR
     DTPDFRVLAC GGDGTVGWIL DCIDKANFAK HPPVAVLPLG TGNDLARCLR WGGGYEGGSL
     TKILKDIEQS PLVMLDRWHL EVIPREEVEN GDQVPYSIMN NYFSIGVDAS IAHRFHVMRE
     KHPEKFNSRM KNKLWYFEFG TSETFAATCK KLHDHIELEC DGVGVDLSNI FLEGIAILNI
     PSMYGGTNLW GENKKNRAVI RESRKGVTDP KELKFCVQDL SDQLLEVVGL EGAMEMGQIY
     TGLKSAGRRL AQCASVTIRT NKLLPMQVDG EPWMQPCCTI KITHKNQAPM MMGPPQKSSF
     FSLRRKSRSK D
//
